ZA200706691B - Process for preparing lansoprazole - Google Patents

Process for preparing lansoprazole

Info

Publication number
ZA200706691B
ZA200706691B ZA200706691A ZA200706691A ZA200706691B ZA 200706691 B ZA200706691 B ZA 200706691B ZA 200706691 A ZA200706691 A ZA 200706691A ZA 200706691 A ZA200706691 A ZA 200706691A ZA 200706691 B ZA200706691 B ZA 200706691B
Authority
ZA
South Africa
Prior art keywords
lansoprazole
preparing
preparing lansoprazole
directed
pharmaceutical composition
Prior art date
Application number
ZA200706691A
Other languages
English (en)
Inventor
Kotar-Jordan Berta
Vrecer Franc
Segula Zakelj Mojca
Ritlop Gregor
Original Assignee
Krka Tovarna Zdravil D D Nova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil D D Nova filed Critical Krka Tovarna Zdravil D D Nova
Publication of ZA200706691B publication Critical patent/ZA200706691B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
ZA200706691A 2005-01-14 2007-08-13 Process for preparing lansoprazole ZA200706691B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05000663A EP1681056A1 (fr) 2005-01-14 2005-01-14 Procédé de préparation du lansoprazole

Publications (1)

Publication Number Publication Date
ZA200706691B true ZA200706691B (en) 2008-09-25

Family

ID=34933288

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706691A ZA200706691B (en) 2005-01-14 2007-08-13 Process for preparing lansoprazole

Country Status (14)

Country Link
US (1) US7662968B2 (fr)
EP (3) EP1681056A1 (fr)
CN (2) CN101824028A (fr)
AT (1) ATE475419T1 (fr)
AU (1) AU2006205818A1 (fr)
CA (1) CA2594821A1 (fr)
DE (1) DE602006015771D1 (fr)
EA (1) EA015043B1 (fr)
NO (1) NO20074086L (fr)
NZ (1) NZ556706A (fr)
SI (2) SI2308492T1 (fr)
UA (1) UA90293C2 (fr)
WO (1) WO2006074952A1 (fr)
ZA (1) ZA200706691B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2579665C (fr) * 2004-09-13 2014-03-18 Takeda Pharmaceutical Company Limited Procede et appareil destines a produire un compose oxyde
WO2008035189A1 (fr) * 2006-09-22 2008-03-27 Orchid Chemicals & Pharmaceuticals Limited Procédé de purification du lansoprazole
ITMI20062481A1 (it) * 2006-12-22 2008-06-23 Recordati Chem Pharm Processo per la preparazione di lansoprazolo forma i microcristallino
WO2008132727A2 (fr) * 2007-04-26 2008-11-06 Technion Research And Development Foundation Ltd Administration orale de protéines et de peptides
SI22806A (sl) * 2008-06-23 2009-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalinične oblike natrijevega rabeprazola
EP2501383A4 (fr) * 2009-11-20 2013-06-26 Handa Pharmaceuticals Llc Formulation orale pour le dexlansoprazole
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN102180865B (zh) * 2011-03-17 2013-01-16 浙江工业大学 一种兰索拉唑的合成方法
CN102558154B (zh) * 2012-02-24 2014-01-08 海南锦瑞制药股份有限公司 一种兰索拉唑结晶化合物及其肠溶胶囊、及制备方法
CN102838537B (zh) * 2012-09-18 2014-04-09 寿光富康制药有限公司 一种兰索拉唑中间体的制备方法
CN103539729A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种氯甲基吡啶衍生物的工业化生产方法
CN103539728A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种拉唑类药物中间体氯甲基吡啶衍生物的合成方法
CN103664750A (zh) * 2013-12-09 2014-03-26 惠州市莱佛士制药技术有限公司 一种拉唑氯代物的合成方法
CN104083330A (zh) * 2014-02-21 2014-10-08 杭州长典医药科技有限公司 兰索拉唑钠特种超细粉体冻干制剂及其制备方法
CN104447696B (zh) * 2014-11-19 2016-08-17 上海泰坦科技股份有限公司 兰索拉唑的合成工艺
CN104557693B (zh) * 2015-01-16 2017-01-04 江苏中邦制药有限公司 一种3,5-二甲基-4-硝基吡啶-n-氧化物的合成方法
CN104592107B (zh) * 2015-01-16 2017-01-11 江苏中邦制药有限公司 一种2,3-二甲基-4-硝基吡啶-n-氧化物的合成方法
CN104817492B (zh) * 2015-05-22 2018-05-18 抚州三和医药化工有限公司 兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基）吡啶的分离纯化方法
CN106928191B (zh) * 2015-12-30 2019-09-03 河南康达制药有限公司 一种兰索拉唑的制备工艺
CN106543146A (zh) * 2016-11-10 2017-03-29 石家庄市度智医药科技有限公司 一种右兰索拉唑的制备方法
CN106749186B (zh) * 2016-12-29 2019-03-05 南京海融制药有限公司 一种右兰索拉唑钠的新晶型及其制备方法
CN106727381B (zh) * 2016-12-29 2020-07-07 南京海融制药有限公司 一种右兰索拉唑钠的口崩片及其制备方法
CN106619520B (zh) * 2016-12-29 2019-08-06 南京海融制药有限公司 一种右兰索拉唑钠的干混悬剂及其制备方法
CN108947967B (zh) * 2018-08-24 2020-10-30 迪嘉药业集团有限公司 一种兰索拉唑的制备方法
WO2020048449A1 (fr) 2018-09-03 2020-03-12 正大天晴药业集团股份有限公司 Composition pharmaceutique solide contenant un dérivé de 1,3,5-triazine ou un sel de ce dernier
CN114163419A (zh) * 2021-12-24 2022-03-11 辰欣药业股份有限公司 一种兰索拉唑的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
WO1999002521A1 (fr) * 1997-07-11 1999-01-21 Eisai Co., Ltd. Procedes d'elaboration de derives pyridiniques
DK1180020T4 (da) * 1999-05-27 2009-10-05 Acusphere Inc Poröse lægemiddelmatrixer og fremgangsmåder til fremstilling deraf
PL333847A1 (en) * 1999-06-18 2001-01-02 Inst Farmaceutyczny Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
KR20100002278A (ko) * 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정
JP2004524303A (ja) * 2001-02-02 2004-08-12 テバ ファーマシューティカル インダストリーズ リミティド 置換された２−（２−ピリジルメチル）スルフィニル−１ｈ−ベンゾイミダゾール類の製造方法
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
NZ530168A (en) 2001-07-16 2004-08-27 Janssen Pharmaceutica Nv Improved process for preparing benzimidazole-type compounds
CN1681802A (zh) * 2002-03-27 2005-10-12 特瓦制药工业有限公司 兰索拉唑多晶型和其制备方法
JP4115751B2 (ja) * 2002-05-31 2008-07-09 株式会社パーマケム・アジア 微水ベンズイミダゾール系化合物の製法
WO2004011455A1 (fr) * 2002-07-26 2004-02-05 Teva Pharmaceutical Industries Ltd. Preparation de lansoprazole et composes connexes

Also Published As

Publication number Publication date
EP2308492B1 (fr) 2016-09-14
NO20074086L (no) 2007-10-10
EP2308492A1 (fr) 2011-04-13
CN101137371A (zh) 2008-03-05
CN101137371B (zh) 2011-05-25
EA200701461A1 (ru) 2008-02-28
SI2308492T1 (sl) 2017-02-28
AU2006205818A1 (en) 2006-07-20
CN101824028A (zh) 2010-09-08
US20070259049A1 (en) 2007-11-08
SI1838314T1 (sl) 2010-11-30
EP1838314A1 (fr) 2007-10-03
NZ556706A (en) 2009-11-27
WO2006074952A1 (fr) 2006-07-20
DE602006015771D1 (de) 2010-09-09
UA90293C2 (en) 2010-04-26
EP1838314B1 (fr) 2010-07-28
ATE475419T1 (de) 2010-08-15
CA2594821A1 (fr) 2006-07-20
EP1681056A1 (fr) 2006-07-19
US7662968B2 (en) 2010-02-16
EA015043B1 (ru) 2011-04-29

Similar Documents

Publication Publication Date Title
ZA200706691B (en) Process for preparing lansoprazole
IL185016A0 (en) Compounds for the treatment of proliferative disorders
GB2430881B (en) Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
IL180546A0 (en) Novel piperidine derivative for the treatment of depression
EP1871363A4 (fr) Processus a etapes combinees pour compositions pharmaceutiques
ZA200803987B (en) Novel process and formulations
IL190666A0 (en) Process for the preparation of insulin conjugates
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
EP1834624A4 (fr) Préparation thérapeutique et procédé d'élaboration de ladite préparation
ZA200601910B (en) Process for the preparation of organosilances
EP1667827A4 (fr) Procede de traitement du bois
IL190325A (en) A process for making loopfin
ZA200807701B (en) Differentiating therapeutic composition
GB0526292D0 (en) A composition for use in the treatment of a surface
ZA200805656B (en) Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
ZA200804778B (en) New process for the preparation of esomeprazole non-salt form
ZA200705079B (en) Novel pharmaceutical composition useful for vaccines
GB2423228B (en) Net-plate set for horticulture or ornament
ZA200601604B (en) Composition for treating HIV
IL188104A0 (en) Compounds useful for treating bipolar disorders
ZA200702864B (en) Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
ZA200603322B (en) Process for material treatment
ZA200603323B (en) Process for material treatment